Welcome to International Network for Natural Sciences | INNSpub

Prevalence and comparative analysis of HBs, HCV, CRP, T.B and H. pylori in drug addicted individuals from local population of Charsadda, Khyber Pakhtunkhwa, Pakistan

Research Paper | April 1, 2018

| Download 6

Hasnain Jan, Ayesha Naeem, Sajjad Ali Shah, Wali Muhammad, Muhammad Asad Ullah, Shah Faisal, Hazrat Usman, Ayyaz Khan, Sifatullah

Key Words:

Int. J. Biosci.12( 4), 433-441, April 2018

DOI: http://dx.doi.org/10.12692/ijb/12.4.433-441


IJB 2018 [Generate Certificate]


The main objective of the current study was to evaluate the prevalence of infectious diseases in drug addicts compared to normal individuals. The study was conducted in Biotechnology Department Bacha Khan University Charsadda, KPK, Pakistan. Total 80 drug addict’s blood samples including smoker, alcoholic, cocaine and cannabis users (20 of each) were collected from age range 25-50 years from local area in EDTA tube and multiple diagnostic assay were performed. Results indicated that total of 22.5% HBs, 50% HCV, 17.5% CRP, 18.5% T.B and 65% H. pylori prevalence was found in each drug category. The results suggested an interaction on the additive scale between drugs use and HBV infection, and an interaction on the multiplicative scale with HCV infection. Additional studies are required to investigate the possible biological role of drugs in the development of infectious forms of HBs, HCV, CRP, T.B and H. Pylori and effect on expression of gene and DNA of addicted individuals. There is dire need of awareness in public about the lethal effects of use of these addictive drugs.


Copyright © 2018
By Authors and International Network for
Natural Sciences (INNSPUB)
This article is published under the terms of the Creative
Commons Attribution Liscense 4.0

Prevalence and comparative analysis of HBs, HCV, CRP, T.B and H. pylori in drug addicted individuals from local population of Charsadda, Khyber Pakhtunkhwa, Pakistan

Alberg AJ, Brock MV, Ford JG, Samet JM, Spivack SD. 2013. “Epidemiology of lung cancer: Diagnosis and management of lung cancer: American College of Chest Physicians evidence-based clinical practice guidelines.” Chest 143(5), e1S-e29S.

Awaisu AMHN, Mohamed NA Aziz SAS, Sulaiman NM, Noordin AR, Muttalif A, Mahayiddin A. 2010. “Tobacco use prevalence, knowledge, and attitudes among newly diagnosed tuberculosis patients in Penang State and Wilayah Persekutuan Kuala Lumpur, Malaysia.” Tobacco induced diseases 8(1), 3.

Basu S, Stuckler D, Bitton A, Glantz SA. 2011. “Projected effects of tobacco smoking on worldwide tuberculosis control: Mathematical Modelling Analysis.” Bmj 343, d5506.

Brunet LEE, Moodie K, Rollet C, Cooper S, Walmsley M, Potter MB, Klein CC, Investigators IC. 2013. “Marijuana smoking does not accelerate progression of liver disease in HIV–hepatitis C coinfection: A longitudinal cohort analysis.” Clinical Infectious Diseases 57(5), 663-670.

Cagienard F, Schulzki T, Furlong P, Reinhart W. 2013. “Cocaine induces a reversible stomatocytosis of red blood cells and increases blood viscosity.” Clinical Hemorheology and Microcirculation 55(3), 321-329.

Das SK. 2003. “Harmful health effects of cigarette smoking.” Molecular and Cellular Biochemistry 253(1-2), 159-165.

Degenhardt L, Coffey C, Carlin JB, Swift W, Moore E, Patton GC. 2010. “Outcomes of occasional cannabis use in adolescence: 10-year follow-up study in Victoria, Australia.” The British Journal of Psychiatry 196(4), 290-295.

Furie MB, Raffanello JA, Gergel EI, Lisinski TJ, Horb LD. 2000. “Extracts of smokeless tobacco induce pro-inflammatory changes in cultured human vascular endothelial cells.” Immunopharmacology 47(1), 13-23.

Ghasemian R, Najafi N, Yadegarinia D, Alian S. 2009. “Association between cigarette smoking and pulmonary tuberculosis in men: A case-control study in Mazandaran, Iran.” Archives of Clinical Infectious Diseases 4(3), 135-141.

Goodwin CS, Mendall MM, Northfield TC. 1997. “Helicobacter pylori infection.” The Lancet 349(9047), 265-269.

Gray B, Roberts M. 1988. Analysis of chemical kinetic systems over the entire parameter space-I. The Sal’nikov thermokinetic oscillator. Proc. R. Soc. Lond. A, The Royal Society.

Greydanus D, Hawver EK, Greydanus MM, Merrick J. 2013. “Marijuana: current concepts.” Frontiers in public health 1, 42.

Happel KI, Dubin PJ, Zheng M, Ghilardi N, Lockhart C, Quinton LJ, Odden AR, Shellito JE, Bagby GJ, Nelson S. 2005. “Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae.” Journal of Experimental Medicine 202(6), 761-769.

Hoffmann D, Brunnemann K, Gori G, Wynder E. 1975. On the carcinogenicity of marijuana smoke. Recent advances in phytochemistry, Springer 63-81.

Holt P. 1988. “Environmental pollutants as co-factors in IgE production.” Current opinion in immunology 1(4), 643-646.

Kelley KW, Dantzer R. 2011. “Alcoholism and inflammation: neuroimmunology of behavioral and mood disorders.” Brain, Behavior and Immunity     25, S13-S20.

Keramat F, Eini P, Majzoobi M. 2011. “Seroprevalence of HIV, HBV and HCV in persons referred to hamadan behavioral counseling center, west of Iran.” Iranian Red Crescent Medical Journal 13(1), 42.

Kim JJ, Lee JH, Jung H-Y, Lee GH, Cho JY, Ryu CB, Chun HJ, Park JJ, Lee WS, Kim HS. 2007. “EMR for early gastric cancer in Korea: A multicenter retrospective study.” Gastrointestinal Endoscopy 66(4), 693-700.

Konturek S, Bielański W, Płonka M, Pawlik T, Pepera J, Konturek P, Czarnecki J, Penar A, Jedrychowski W. 2003. “Helicobacter pylori, non-steroidal anti-inflammatory drugs and smoking in risk pattern of gastroduodenal ulcers.” Scandinavian Journal of Gastroenterology 38(9), 923-930.

Kruse GR, Barbour R, Heimer R, Shaboltas AV, Toussova OV, Hoffman IF, Kozlov AP. 2009. “Drug choice, spatial distribution, HIV risk, and HIV prevalence among injection drug users in St. Petersburg, Russia.” Harm Reduction Journal 6(1), 22.

Lao XQ, Jiang CQ, Zhang WS, Adab P, Lam TH, Cheng KK, Thomas GN. 2009. “Smoking, smoking cessation and inflammatory markers in older Chinese men: The Guangzhou Biobank Cohort Study.” Atherosclerosis 203(1), 304-310.

Lau DC, Dhillon B, Yan H, Szmitko PE, Verma S. 2005. “Adipokines: molecular links between obesity and atheroslcerosis.” American Journal of Physiology-Heart and Circulatory Physiology 288(5), H2031-H2041.

Libby P, Ridker PM, Maseri A. 2002. “Inflammation and atherosclerosis.” Circulation 105(9), 1135-1143.

Lopez-Garcia E, Schulze MB, Meigs JB, Manson JE, Rifai N, Stampfer MJ, Willett WC, Hu FB. 2005. “Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction.” The Journal of nutrition 135(3), 562-566.

MatheI C, Robaeys G, Van Ranst M, Van Damme P, Buntinx F. 2004. “Molecular epidemiology of hepatitis C among drug users, correlation with clinical parameters, sexual behaviour and drug-related risk behaviour.” Clinical Microbiology & Infection Supplement 10, 444.

Mezey E, Kolman C, Diehl A, Mitchell M, Herlong H. 1988. “Alcohol and dietary intake in the development of chronic pancreatitis and liver disease in alcoholism.” The American Journal of Clinical Nutrition 48(1), 148-151.

Moy KA, Fan Y, Wang R, Gao Y-T, Mimi CY, Yuan J-M. 2010. “Alcohol and tobacco use in relation to gastric cancer: a prospective study of men in Shanghai, China.” Cancer Epidemiology and Prevention Biomarkers 1055-9965. EPI-1010-0362.

Neuman MG. 2003. “Cytokines-central factors in alcoholic liver disease.” Alcohol Research and Health 27, 307-316.

O’Loughlin J, Lambert M, Karp I, McGrath J, Gray-Donald K, Barnett TA, Delvin EE, Levy E, Paradis G. 2008. “Association between cigarette smoking and C-reactive protein in a representative, population-based sample of adolescents.” Nicotine & Tobacco Research 10(3), 525-532.

Öner S, Yapici G, Şaşmaz CT, Kurt AÖ, Buğdayci R. 2011. “Hepatitis B, hepatitis C, HIV, and VDRL seroprevalence of blood donors in Mersin, Turkey.” Turkish Journal of Medical Sciences 41(2), 335-341.

Ozer A, akupogullari YY, Beytur A, Beytur L, Koroglu M. 2011. “Risk factors of hepatitis B virus infection in Turkey: A population-based, case-control study: Risk Factors for HBV Infection.” Hepatitis Monthly 11(4), 263.

Pablos-Méndez A, Knirsch C, Graham A, Barr MR, Lerner BH, Frieden TR. 1997. “Nonadherence in tuberculosis treatment: predictors and consequences in New York City.” The American Journal of Medicine 102(2), 164-170.

Rajavashisth TB, Shaheen M, Norris KC, Pan D, Sinha SK, Ortega J, Friedman TC. 2012. “Decreased prevalence of diabetes in marijuana users: cross-sectional data from the National Health and Nutrition Examination Survey (NHANES) III.” BMJ Open 2(1), e000494.

Raviglione MC, Snider Jr D, Kochi A. 1995. “Global epidemiology of tuberculosis.” Morbidity and mortality of a worldwide epidemic. JAMA 273(3), 220-226.

Rosenstock S, Kay L, Rosenstock C, Andersen L, Bonnevie O, Jørgensen T. 1997. “Relation between Helicobacter pylori infection and gastrointestinal symptoms and syndromes.” Gut 41(2), 169-176.

Shaler CR, Horvath CN, McCormick S, Jeyanathan M, Khera A, Zganiacz A, Kasinska J, Stampfli MR, Xing Z. 2013. “Continuous and discontinuous cigarette smoke exposure differentially affects protective Th1 immunity against pulmonary tuberculosis.” PLoS One 8(3), e59185.

Shinchi K, Ishii H, Imanishi K, Kono S. 1997. “Relationship of cigarette smoking, alcohol use, and dietary habits with Helicobacter pylori infection in Japanese men.” Scandinavian Journal of Gastroenterology 32(7), 651-655.

Smart RG, Mann RE. 1992. “Alcohol and the epidemiology of liver cirrhosis.” Alcohol Research and Health 16(3), 217.

Szabo G, Mandrekar P, Catalano D. 1995. “Inhibition of superantigen‐induced T cell proliferation and monocyte IL‐1β, TNF‐α, and IL‐6 production by acute ethanol treatment.” Journal of Leukocyte Biology 58(3), 342-350.

Tiwari A, Moghal M, Meleagros L. 2006. Life threatening abdominal complications following cocaine abuse, SAGE Publications Sage UK: London, England.

Wang C-S, Chang T-T, Yao W-J, Chou P. 2002. “Comparison of hepatitis B virus and hepatitis C virus prevalence and risk factors in a community-based study.” The American Journal of Tropical Medicine and Hygiene 66(4), 389-393.

Wannamethee SG, Lowe GD, Shaper AG, Rumley A, Lennon L, Whincup PH. 2005. “Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease.” European Heart Journal 26(17), 1765-1773.

Yenen O, Beyazyürek M, Keskin K, Çavuşlu Ş, Sakarya S, Altunay H. 1993. “Prevalence of HBsAg, Anti-HBc, anti-HCV, anti-HTLV-1, anti-HIV-1/2 in intravenous drug abusers.” Klimik Derg 6, 35-36.

Zhang L-J, Wang S-Y, Huo X-H, Zhu Z-L, Chu J-K, Ma J-C, Cui D-S, Gu P, Zhao Z-R, Wang M-W. 2009. “Anti-Helicobacter pylori therapy followed by celecoxib on progression of gastric precancerous lesions.” World Journal of Gastroenterology: WJG 15(22), 2731.

Zidan A, Scheuerlein H, Schüle S, Settmacher U, Rauchfuss F. 2012. “Epidemiological pattern of hepatitis B and hepatitis C as etiological agents for hepatocellular carcinoma in iran and worldwide.” Hepatitis Monthly 12(10 HCC).